These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 22198887)

  • 21. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatorenal syndrome.
    Ginès P; Guevara M; Arroyo V; Rodés J
    Lancet; 2003 Nov; 362(9398):1819-27. PubMed ID: 14654322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute kidney injury and hepatorenal syndrome in cirrhosis.
    Egerod Israelsen M; Gluud LL; Krag A
    J Gastroenterol Hepatol; 2015 Feb; 30(2):236-43. PubMed ID: 25160511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Renal impairment in liver diseases].
    Gerbes AL; Gülberg V
    Praxis (Bern 1994); 2006 Oct; 95(40):1535-8. PubMed ID: 17048410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.
    Arroyo V
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():49-54; discussion 55-6. PubMed ID: 15335402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatorenal syndrome: a dreaded complication of end-stage liver disease.
    Cárdenas A
    Am J Gastroenterol; 2005 Feb; 100(2):460-7. PubMed ID: 15667508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hepatorenal syndrome].
    Baccaro ME; Guevara M
    Gastroenterol Hepatol; 2007 Nov; 30(9):548-54. PubMed ID: 17980134
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatorenal syndrome.
    Guevara M; Ginès P
    Dig Dis; 2005; 23(1):47-55. PubMed ID: 15920325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
    Fagundes C; Ginès P
    Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatorenal syndrome: a review.
    Testino G; Ferro C
    Hepatogastroenterology; 2010; 57(102-103):1279-84. PubMed ID: 21410072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hepatorenal syndrome].
    Mijac D; Kezić A; Stojimirović B
    Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
    Lenz K; Buder R; Lohr G; Piringer P; Voglmayr M
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):440-6. PubMed ID: 27241778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatorenal syndrome: from physiopathology to treatment].
    Aguillon D; Seguin P; Mallédant Y
    Ann Fr Anesth Reanim; 2003 Jan; 22(1):30-8. PubMed ID: 12738017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and treatment of hepatorenal syndrome.
    Ginès P
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.
    Durand F; Graupera I; Ginès P; Olson JC; Nadim MK
    Am J Kidney Dis; 2016 Feb; 67(2):318-28. PubMed ID: 26500178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatorenal syndrome.
    Bataller R; Ginès P; Guevara M; Arroyo V
    Semin Liver Dis; 1997; 17(3):233-47. PubMed ID: 9308128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatorenal syndrome].
    Radziszewski A; Sułowicz W
    Przegl Lek; 2006; 63(7):573-8. PubMed ID: 17203812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.